Related references
Note: Only part of the references are listed.Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility
Joanne G. Wildenbeest et al.
ANTIVIRAL THERAPY (2012)
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus
Susanne C. Feil et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
The Human Rhinovirus: Human-Pathological Impact, Mechanisms of Antirhinoviral Agents, and Strategies for Their Discovery
Judith M. Rollinger et al.
MEDICINAL RESEARCH REVIEWS (2011)
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3
Michaela Schmidtke et al.
ANTIVIRAL RESEARCH (2009)
Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS
Oliver Korb et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution
Ann C. Palmenberg et al.
SCIENCE (2009)
Selective Inhibitors of Picornavirus Replication
Armando M. De Palma et al.
MEDICINAL RESEARCH REVIEWS (2008)
The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe
JD Ma et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril
RM Ledford et al.
ANTIVIRAL RESEARCH (2005)
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril:: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment
M Schmidtke et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication
VA Makarov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
VP1 sequencing of all human rhinovirus serotypes: Insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds
RM Ledford et al.
JOURNAL OF VIROLOGY (2004)
In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: Novel capsid-binding inhibitors with potent antipicornavirus activity
DL Barnard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1
M Schmidtke et al.
JOURNAL OF VIROLOGICAL METHODS (2001)
Share Paper
